RB ASSOCIATED PROTEIN 46 AND BREAST CANCER PROGRESSION

描述：(改编自《调查员摘要》)：基于他们 初步数据显示RbAp46的表达水平在 乳腺增生性疾病在MCF10AT异种移植模型中的研究进展 在恶性乳腺癌细胞中，研究人员建议：1.研究 结构性表达对雌激素刺激的促进性反应的影响 MCF10AT异种移植模型，检测RbAp46在人体内的表达水平 临床标本采用免疫组织化学和/或RT-PCR。2.研究 RbAp46与其产物相互作用的生物学意义 BRCA1在体内和体外的结合试验，作为免疫共沉淀和 GST捕获分析，以及RbAp46和BRCA1在 细胞周期和暴露于DNA损伤剂后。3.研究分子 RbAp46抑制细胞生长和抑制肿瘤的机制 通过检测RAS通路在MCF10At细胞中的转化，以及结构/ 功能分析以确定RbAp46的结构域 它的生长抑制及其与BRCA1的相互作用。

DESCRIPTION: (Adapted from the Investigator's Abstract): Based on their preliminary data that levels of RbAp46 expression decline during the progression of proliferative breast disease in the MCF10AT xenograft model and in malignant breast cancer cells, the investigators propose to: 1. Study the effects of constitutive expression on estrogen-stimulated progression using the MCF10AT xenograft model, and examine the levels of RbAp46 expression in human clinical samples using immunohistochemistry and/or RT-PCR. 2. Study the biological significance of the interaction between RbAp46 and the product of BRCA1 using in vivo and in vitro binding assays, as co-immunoprecipitation and GST capture assays, and RbAp46 and BRCA1 interaction and co-localization during the cell cycle and after exposure to DNA damage agents. 3. Study the molecular mechanisms by which RbAp46 inhibits cell growth and suppresses malignant transformation by examining the Ras pathway in MCF10At cells, and structure/ functional analyses to determine the domains of RbAp46 that are required for its growth inhibition and interaction with BRCA1.